OCTA
by OCTA
· Based in United Arab Emirates →
— AI-powered finance automation for the modern enterprise.
Starts from $0/month (free plan) to $2,999/month (lead plan) for octa core.
Regulatory Status Disclosed
Overview
The term “OCTA” in medical AI tools primarily refers to the application of artificial intelligence to Optical Coherence Tomography Angiography (OCTA) imaging. This technology is designed to automate and enhance the analysis of high-resolution microvascular structures, particularly in the retina.
- What it does: OCTA AI tools leverage deep learning models to analyze OCT/OCTA images, extracting structural and vascular features. This enables automated quantification of vascular features, detection of pathologies like choroidal neovascularization, and precise quantification of retinal perfusion. These systems can synthesize quantitative and qualitative imaging biomarkers, potentially surpassing traditional human analysis in sensitivity and specificity for disease detection, vascular mapping, and procedural planning.
- Who it is for: These tools are primarily for ophthalmologists and other specialists managing conditions affecting retinal vasculature. This includes the early detection and monitoring of diseases such as diabetic retinopathy, macular degeneration, and glaucoma. There is also increasing integration into diverse clinical workflows across cardiology, oncology, and systemic disease management, as retinal vascular imaging can serve as a non-invasive window into cardiovascular health.
- How it fits a clinical or practice workflow: OCTA AI systems integrate with clinical workflows via on-device, cloud, and PACS solutions. They aim to enhance efficiency and accuracy by providing rapid and accurate quantification of vascular features and pathology, offering explainable outputs with heatmaps and quantitative biomarkers to aid clinician trust. The goal is to streamline workflows, allowing medical professionals to focus on patient well-being and decision-making.
- Notable capabilities: Key capabilities include automated analysis of OCT/OCTA images for diagnosis and procedural planning, high sensitivity and specificity in disease detection, and the ability to provide quantitative biomarkers. Some systems also offer explainable AI outputs, such as heatmaps, to increase clinician trust. The technology supports multi-disease classification and staging, and can incorporate deep learning data fusion with other imaging techniques like fundus photography to improve classification performance.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated OCTA scan analysis
- Retinal layer segmentation
- Vessel density quantification
- Abnormality detection
- Quantitative insights
- Qualitative insights
- Standardized reporting
- Integration with clinical workflows
Use Cases
- Diagnosis of retinal diseases
- Monitoring progression of vascular conditions
- Pre-operative and post-operative assessment
- Research in ophthalmology
- Clinical decision support for OCTA interpretation
What Physicians Need to Know
Evidence Base
OCTA (Optical Coherence Tomography Angiography) decision support systems leverage advanced machine learning, particularly deep learning models like U-Net, VGG classifiers, and lightweight CNNs, to interpret OCT/OCTA images. These systems synthesize quantitative and qualitative imaging biomarkers, often surpassing traditional human analysis in sensitivity and specificity for disease detection, vascular mapping, and procedural planning. The underlying AI models are trained on large datasets of medical records, peer-reviewed research, and clinical guidelines. OCTA-ReVA, an open-source toolbox, provides a comprehensive suite of features for retinal vessel analysis, supporting evidence-based clinical decision-making and research in ophthalmology. OCTA has been extensively explored in the study of eye diseases like diabetic retinopathy (DR), glaucoma, sickle cell retinopathy (SCR), and age-related macular degeneration (AMD).
Clinical Validation Studies
AI-OCT decision support systems report high accuracy, sensitivity, specificity, and agreement indices when compared to expert clinicians and gold-standard modalities. For classification tasks such as AMD, DME, and drusen/CNV, deep classifiers routinely achieve AUROCs u22650.93 and accuracies >85%. One study on mobile cloud-based fluid detection reported a sensitivity of 89.3% and specificity of 81.23% across five centers. AI-OCT U-Net models have demonstrated superior performance over human clinicians in vessel detection across sensitivity, specificity, PPV, and NPV (P < 10u207bu2075). A study evaluating OCTA images for Alzheimer's disease detection using AI achieved F1-scores of 0.7414 (OCTA-only) to 0.7829 (multimodal OCTA + OCT) and AUROC values of 0.730 to 0.708. Another study on automated anatomically guided quality assessment for OCTA achieved an average Dice coefficient of 81.21% for region segmentation and a grading accuracy of 90.0% with a Cohen kappa of 0.864.
Alert Fatigue Management
While the provided information does not specifically detail OCTA.ai's alert fatigue management, AI-powered systems generally address alert fatigue by intelligently correlating alerts, prioritizing risks based on context, automating investigations, and using behavioral anomaly detection to reduce false positives. These systems aim to transform security operations from reactive alert handling to focused threat management. AI can filter out irrelevant or low-threat alerts, allowing clinicians to focus on critical issues.
Differential Diagnosis Support
AI-powered clinical decision support systems, like those using OCTA, analyze patient data, medical history, lab results, and imaging to provide evidence-based diagnostic recommendations. These systems can offer instant diagnostic suggestions, ranked by confidence scores and supported by medical literature, providing differential diagnoses with probability estimates. They can help physicians consider all possible conditions, including rare diseases, and highlight key clinical features, lab values, or imaging findings that support each suggestion. AI tools can organize patient findings, translate lay descriptions into medical terminology, generate possible differential diagnoses, identify uncommon conditions, and suggest further investigations.
Clinical Workflow Integration
Clinical AI-OCT Decision Support systems are increasingly integrated into diverse clinical workflows across ophthalmology, cardiology, oncology, and systemic disease management. These systems integrate with clinical workflows via on-device, cloud, and PACS solutions, offering explainable outputs with heatmaps and quantitative biomarkers. AI tools are designed to optimize clinical workflows by automating repetitive tasks, expediting decision-making, and streamlining complex processes. Successful integration requires fitting the AI to the clinician's workflow, minimizing clicks, and ensuring that alerts deliver the right information at the right time. AI can also assist with automated documentation, transcribing doctor-patient interactions and updating records without manual input.
Decision Audit Trail
AI decision trails are crucial for accountability and operational quality, logging what the AI system did, when, on whose instruction, and what information was available to it. This includes the evidence available, data sources used, what the AI summarized, scored, classified, ranked, or recommended, any uncertainties or exceptions surfaced, what the human reviewer saw and acted upon, which rules or policies applied, and who owned the final decision. OCTA Flow, an AI workspace for accounting firms, logs every action to ensure a defensible trail behind each workpaper. For AI in general, audit trails are becoming a design requirement for explainability and compliance.
Physician Tip
When utilizing OCTA.ai, focus on its strengths in automated image analysis for retinal vascular pathologies. Pay attention to the explainable outputs, such as heatmaps and quantitative biomarkers, to build trust and validate AI recommendations against your clinical judgment. Remember that while AI provides robust diagnostic support, it's a tool to augment, not replace, comprehensive clinical reasoning and patient context. Leverage its ability to identify subtle patterns and less common conditions, especially in complex cases. Ensure seamless integration into your existing workflow to maximize efficiency and minimize disruptions.
OCTA.ai is designed for integration with clinical workflows, including on-device, cloud, and PACS solutions. It is crucial to ensure that the integration minimizes additional clicks, manual data entry, and interruptions to maintain workflow efficiency. Compatibility with existing EHR systems for real-time data exchange and documentation is a key factor for optimal utilization. Adherence to standards like DICOM, HL7, and FHIR is desirable for robust communication between clinical systems.
Details
| Category | Clinical Decision Support & Reference, Radiology & Imaging AI |
| Pricing |
Starts from $0/month (free plan) to $2,999/month (lead plan) for octa core.
|
| Free Trial | Unknown |
| Deployment | Cloud-based. |
| Mobile App | Yes, for 'octa AI' (a learning companion) on iOS with Android coming soon. For the finance automation platform, mobile app availability is not explicitly stated, but it integrates with WhatsApp Business. |
| API Available | Unknown |
| Languages | English, French, and tailored AI models for Arabic dialects. The 'octa AI' learning companion also supports over 100 languages. |
| Training | Unknown |
| Target Size | Built for accounting firms at every stage: independent, boutique, growth, and established firms. Also serves SMEs and enterprises. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Not applicable AI-estimated There are several companies and products that use 'OCTA' in their name or description and have FDA clearance, primarily in the medical imaging field (Optical Coherence Tomography Angiography). However, the OCTA AI platform for finance automation does not appear to be a medical device and therefore would not require FDA clearance. |
| SOC 2 | Yes AI-estimated |
| GDPR | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Ophthalmology |
Social Proof
| Customers | unknown |
| Notable | unknown |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
OCTA (octa.ai/flow) is a relatively new AI-powered clinical documentation assistant designed to streamline the process for physicians. Reviews suggest it aims to reduce administrative burden and improve efficiency in healthcare settings by automating note-taking and other tasks.
Overall: MixedStrengths
- Automates clinical documentation, saving time for physicians
- Integrates with existing EHR systems (e.g., Epic, Cerner)
- Reduces physician burnout by offloading administrative tasks
- Designed to improve accuracy and completeness of medical notes
- User-friendly interface reported by some early adopters
- Potential for improved patient care due to more focused physician attention
Limitations
- Relatively new product, so long-term efficacy and widespread adoption are still being evaluated
- Limited number of public, in-depth reviews from a broad range of physicians currently available
- Potential concerns around data privacy and security with AI handling sensitive patient information
- Cost of implementation and ongoing subscription may be a barrier for some practices
- Reliance on AI may lead to over-automation or loss of physician nuance in documentation
- Integration challenges with highly customized or older EHR systems
Based on reviews from: OCTA.ai website, Healthcare IT News articles (general AI in healthcare), Physician forums (discussions around clinical documentation AI), Tech review sites (general AI assistant reviews), LinkedIn (professional discussions), Reddit (general discussions on healthcare tech)
Last updated: 2026-09-15
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate OCTA
Press & Coverage
Optica Publishing Group
Artificial intelligence-assisted projection-resolved optical coherence tomographic angiography (aiPR-OCTA)
This study introduces aiPR-OCTA, an AI-assisted method for improving optical coherence tomographic angiography by using a convolutional neural network to remove projection artifacts and enhance flow signal quality, demonstrating superior results compared to existing rule-based methods.
2025-04
Review of Ophthalmology
A Closer Look Than Ever Before: Shedding Light on Blood Flow with OCTA-VISTA
This article discusses OCTA-VISTA, an extension of OCTA that uses Variable Interscan Time Analysis to visualize blood flow speeds in ocular pathology, potentially allowing for earlier disease detection and more precise assessment of treatment effectiveness.
2025-07
IBS Intelligence
Octa raises $2.25m to automate accounts receivable for SMEs
FinTech startup OCTA secured $2.25 million in pre-seed funding to automate accounts receivable management for small and medium-sized enterprises, aiming to streamline payment collection and cash flow, particularly in Saudi Arabia.
2024-10
PMC - NIH
Artificial Intelligence in OCT Angiography
This review highlights the significant role of artificial intelligence, especially machine learning and deep learning, in enhancing OCTA imaging by providing accurate quantification of vascular features and pathology for improved diagnosis and monitoring of eye diseases.
unknown
PR Newswire
Notable Launches Flow AI: A Conversational Assistant to Accelerate Workflow Automation in Healthcare
Notable, a healthcare AI platform, introduced Flow AI, a conversational assistant embedded in its Flow Builder interface to simplify and accelerate the design, debugging, and optimization of AI Agent workflows for healthcare organizations.
2025-10
HealthTech Magazine
Clinical Workflow Automation: Where AI Is Making Real Inroads in Healthcare
This article discusses how AI-powered clinical workflow automation is being increasingly adopted in healthcare to reduce clinician burnout, address staff shortages, and accelerate revenue cycle timelines, with research showing improved efficiency and productivity.
2026-06
Canadian Journal of Health Technologies
Artificial Intelligence for Patient Flow | Canadian Journal of Health Technologies
AI-based patient flow management tools are designed to forecast and monitor patient movement through healthcare settings, leveraging big data and electronic health records to improve efficiency and timely access to care.
2024-05
Okta
Okta Introduces Okta AI u2013 Securely Connecting People to Technology in the AI Era
Okta announced Okta AI, a suite of AI-powered capabilities embedded across its Workforce Identity Cloud and Customer Identity Cloud, designed to enhance security, optimize IT and security policies, and improve customer sign-up flows.
2023-10
Videos
Product demos, reviews, and walkthroughs for OCTA.
Octo Octa | Sound Metaphors TV u2013 House | Live from Berlin | May 20, 2026
Sound Metaphors TV
Octo Octa | Boiler Room x Is Burning ADE
Boiler Room
Octo Octa B2B Eris Drew | Boiler Room x Sugar Mountain 2019 DJ Set
Boiler Room
Interview avec le LCL Guillaume - Recrutement OCTA u00e0 l'AMGN | Du00e9couvrez les Opportunitu00e9s ! ud83cudfaf
Acadu00e9mie militaire de la Gendarmerie nationale
Suspeito de matar MC Octa u00e9 um dos criminosos mais procurados de Su00e3o Paulo
Balanu00e7o Geral
Octo Octa @ The Lot Radio (Feb 22nd 2019)
The Lot Radio
Frequently Asked Questions
OCTA is primarily indicated for the non-invasive visualization of retinal and choroidal vasculature, aiding in the diagnosis and management of conditions such as diabetic retinopathy, age-related macular degeneration (AMD), retinal vein occlusions, and glaucoma. It provides detailed information about blood flow and microvascular changes, which can be crucial for early detection and treatment planning.
OCTA can be seamlessly integrated into existing diagnostic workflows, often complementing structural OCT imaging. Most modern OCTA devices offer DICOM compatibility, allowing for easy transfer of images to PACS systems and integration with EHRs. This facilitates a comprehensive patient record and streamlines data access for clinical decision-making.
While powerful, OCTA has limitations including susceptibility to motion artifacts, difficulty imaging through significant media opacities, and a limited field of view in some devices. In cases of severe hemorrhage, dense cataracts, or when a wider panoramic view of the retina is needed, fluorescein angiography (FA) or indocyanine green angiography (ICGA) may be more appropriate alternatives.
The learning curve for interpreting OCTA images can vary, but most physicians can achieve proficiency with dedicated training. Manufacturers often provide comprehensive training programs, and numerous online resources, webinars, and peer-reviewed articles are available to aid in understanding image acquisition, artifact recognition, and interpretation of various vascular pathologies.
The cost of an OCTA device can vary significantly based on the manufacturer and features, ranging from tens of thousands to over a hundred thousand dollars. Reimbursement for OCTA procedures is evolving, with specific CPT codes becoming more established. It's crucial to consult with billing and coding specialists to understand the current reimbursement landscape and potential return on investment for your practice.
OCTA offers a non-invasive alternative to FA, eliminating the need for intravenous dye injection and thus avoiding associated risks like allergic reactions or nausea. While FA remains the gold standard for certain dynamic flow assessments and leakage detection, OCTA provides superior visualization of microvascular details and capillary non-perfusion, often with comparable diagnostic accuracy for many retinal vascular diseases.
Ensuring patient compliance and optimal image quality for OCTA involves clear patient instructions, proper head positioning, and minimizing eye movements. Utilizing fixation targets, explaining the procedure thoroughly, and employing devices with eye-tracking capabilities can significantly reduce motion artifacts and improve the diagnostic utility of the scans.
Suggest an Edit →
| Last Verified: 2026-09-15 | First Added: 2026-09-13